Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18843168 | 0.91 | ALDH1A1 (0.34) | — | |
| SCHEMBL18843113 | 0.90 | HSD11B1 (0.34) | LOXL2HSD11B1HSD17B2ENPP1 | |
| SCHEMBL18843137 | 0.90 | LOXL2 (0.33) | LOXL2HSD11B1 | |
| SCHEMBL18843139 | 0.89 | LMNA (0.30) | — | |
| SCHEMBL18843122 | 0.87 | LOXL2 (0.34) | LOXL2HSD11B1 | |
| SCHEMBL18843147 | 0.87 | HSD11B1 (0.34) | LOXL2HSD11B1HSD17B2ENPP1 | |
| SCHEMBL18843125 | 0.82 | ALDH1A1 (0.33) | — | |
| SCHEMBL18843134 | 0.81 | LOXL2 (0.32) | LOXL2HSD11B1 | |
| SCHEMBL18843143 | 0.80 | LOXL2 (0.34) | LOXL2 | |
| SCHEMBL18843136 | 0.79 | GPR119 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-05-11 | — | — | US | disclosed |
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170133605-A1 | TETRACENOTHIOPHENE DERIVATIVES WITH ALKOXY-C-ALKYNE SOLUBILISING UNITS AND THEIR APPLICATIONS AS ORGANIC SEMICONDUCTORS | ALK, TPR, TTI2 | LOXL2 673/4885HSD11B1 3769/4885HSD17B2 2594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.